Globus Medical, Inc.

Globus Medical, Inc.

GMED·NYSE

$77.95

-0.38%
HealthcareMedical - Devices

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

At a Glance

Live Snapshot
Market Cap$10.51B
EPS3.9800
P/E Ratio21.94
Earnings Date07/30/2026

gmed

Other Current Liabilities

Last Annual Value

357.25M

3-Year CAGR

75%

5-Year CAGR

48%

10-Year CAGR

27%

Globus Medical, Inc.

Globus Medical, Inc. Competitors Analysis of Other Current Liabilities

GMED · NYSE
CompanyOther Current Liabilities
CAGR 3Y
CAGR 5Y
CAGR 10Y
357.25M
21.0%41.0%25.3% 
234.61M
-0.4%-2.2%17.7%
7.37B
N/AN/A39.4%
232.59M
1.6%3.6%6.9%
132.16M
N/AN/A24.8%
680.00M
N/AN/AN/A
134.78M
43.3%21.6%33.0%
DVA logo
DaVita Inc.
NYSE:DVA
1.09B
-8.4%-2.5%-5.4%
141.20M
-4.4%2.0%2.0%
Globus Medical, Inc.

Globus Medical, Inc. Fair Value Envelope

GMED · NYSE

Our analysis suggests that GMED has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $77.95, this represents a potential HIDDEN relative to our calculated worth for Globus Medical, Inc..

Intrinsic Value
Current Price: $77.95